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Stable addition of U2 small nuclear ribonucleoprotein (snRNP) to
form the prespliceosome is the first ATP-dependent step in splicing,
and it requires the DEXDH box ATPase Prp5p. However, prespli-
ceosome formation occurs without ATP in extracts lacking the U2
snRNP protein Cus2p. Here we show that Prp5p is required for the
ATP-independent prespliceosome assembly that occurs in the ab-
sence of Cus2p. Addition of recombinant Cus2p can restore the ATP
dependence of prespliceosome assembly, but only if it is added
before Prp5p. Prp5p with an altered ATP-binding domain (Prp5-
GNTp) can support growth in vivo, but only in a cus2 deletion
strain, mirroring the in vitro results. Other Prp5 ATP-binding do-
main substitutions are lethal, even in the cus2 deletion strain, but
can be suppressed by U2 small nuclear RNA mutations that hyper-
stabilize U2 stem IIa. We infer that the presence of Cus2p and stem
IIa-destabilized forms of U2 small nuclear RNA places high de-
mands on the ATP-driven function of Prp5p. Because Prp5p is not
dispensable in vitro even in the absence of ATP, we propose that
the core Prp5p function in bringing U2 to the branchpoint is not
directly ATP-dependent. The positive role of Cus2p in rescuing
mutant U2 can be reconciled with its antagonistic effect on Prp5
function in a model whereby Cus2p first helps Prp5p to activate the
U2 snRNP for prespliceosome formation but then is displaced by
Prp5p before or during the stabilization of U2 at the branchpoint.
pre-mRNA splicing  branch site  RNA helicase  commitment
complex  mRNA
Pre-mRNA splicing is a dynamic process, occurring within alarge ribonucleoprotein complex called the spliceosome.
Multiple ATP-dependent RNA and protein rearrangements
take place before, between, and after the two transesterifications
required to produce mature mRNAs (for reviews, see refs. 1–5).
Important unsolved questions in splicing concern how these
rearrangements are catalyzed at each ATP-dependent step. A
total of eight members of the DEXDH family of ATP-
dependent RNA helicases have been assigned roles in splicing,
each apparently responsible for catalyzing a specific transition in
a particular splicing complex in conjunction with ATP hydrolysis
(4, 5). In yeast, Prp5p and Sub2p have been implicated in U2
small nuclear ribonucleoprotein (snRNP) recruitment (6–11);
Prp28p has been implicated in the addition of the U4U6.U5
tri-snRNP (12) and destabilization of U1 snRNP (13); Brr2p has
been implicated in the destabilization of U4 snRNP before
catalysis (14); Prp2p, Prp16p, and Prp22p have been implicated
in the activation of the complex for the cleavage-ligation reac-
tions of the pre-mRNA substrate (15–18); and Prp22p and
Prp43p have been implicated in the release of mRNA and
disassembly of the splicing complex (17–19). RNA mutations
consistent with hyperstabilization or destabilization of specific
spliceosomal RNA duplexes cause consistent changes in the
demand for DEXDH protein function in genetic tests (4), but
the molecular nature of these spliceosomal transitions and how
these proteins accelerate them is largely unclear. A common
theme is the activation, release, or stabilization of a distinct
RNA–protein complex.
Some members of the DEXDH protein family can carry out
ATP-dependent RNA helicase reactions using model nucleic
acid substrates (20–22). However, in some cases these may bear
little resemblance to the natural substrate. Removal of proteins
from RNA is also a possible function for this class of proteins (20,
23). Because the core conserved structural elements of this
family are known to be important for RNA binding and ATP-
dependent RNA unwinding (24), it has been assumed that these
activities must reflect a core biochemical function of the family,
with substrate specificity and timing restricted by particular
characteristics of each family member. However, work by Schwer
and Gross (18) shows that the ATP-binding activity of Prp22p is
not required for its role in the second catalytic step of splicing
but is required for mRNA release, suggesting that some key
functions of the DEXDH family may not be strictly ATP-
dependent.
In the case of Prp5p, genetic and biochemical data indicate
that it acts to stabilize the association of U2 snRNP with
pre-mRNA during prespliceosome formation (6, 7, 11, 25). Heat
treatment of splicing extracts from temperature-sensitive prp5-1
yeast prevents prespliceosome formation and splicing in vitro (6),
and this block can be overcome with recombinant Prp5p
(rPrp5p) (7). Annealing of oligonucleotides complementary to
the branchpoint interaction region of U2 small nuclear RNA
(snRNA), a model reaction thought to reflect U2-branchpoint
interaction, is stimulated by Prp5p and ATP in vitro and is
significantly reduced in heat-treated prp5-1 splicing extracts (7,
11). Immunodepletion of hPrp5p from HeLa cell extracts blocks
splicing during or before prespliceosome assembly (25). Thus,
Prp5p has been implicated as the mediator of the ATP require-
ment at this step (6, 7, 11, 27). Recently, splicing extracts lacking
Cus2p have been shown to be relieved of the requirement for
ATP in prespliceosome formation (27). Cus2p, isolated as a
dominant suppressor of U2 snRNA folding mutants in yeast (26),
acts both in support of and in opposition to Prp5p (27). Prp5p
and Cus2p share genetic interactions with SF3a and SF3b
subunit genes, indicative of shared function in prespliceosome
assembly (6, 26, 28, 29). In splicing extracts, Cus2p enforces the
ATP dependence of prespliceosome formation, because prespli-
ceosomes form without ATP in extracts from a cus2 deletion
strain. Despite this, cus2 does not bypass the need for Prp5p,
because temperature-sensitive prp5-1 splicing extracts lacking
Cus2p are not functional (27).
Here we present in vitro and in vivo evidence that Prp5p has
multiple roles in prespliceosome formation, including an ATP-
independent function. Order of addition experiments shows that,
in the absence of Cus2p, the ATP-dependent activity of Prp5p
is unnecessary for prespliceosome assembly in vitro, suggesting it
may have to do with displacing Cus2p. An ATP-binding domain
mutant of Prp5p (GKT to GNT) rescues a prp5 deletion in vivo,
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but only if Cus2p is absent. Other similar mutants (GKT to GAT
or GHT) do not survive even without Cus2p but can be
suppressed by mutant U2 snRNAs in which U2-stem IIa is
hyperstabilized. Taken together, these results demonstrate that
the normally stringent requirement for the ATP-dependent
activity of Prp5p is relaxed when Cus2p is absent, and U2 snRNA
can readily form stem IIa. Furthermore, there exists an under-
lying ATP-independent activity of Prp5p that is essential for
prespliceosome formation. We suggest a model in which Cus2p
helps Prp5p activate the U2 snRNP but then must be removed
from the U2 snRNP before stable association with the pre-
mRNA. In this model, the ATP-requiring activity of Prp5p helps
ensure that competing RNA structures are disrupted to allow
formation of U2-stem IIa and removal of Cus2p. This step could
help the U2 snRNA to base-pair with the pre-mRNA branch-
point.
Methods
In Vitro Splicing and Native Gel Analysis. Splicing extracts were
isolated as described (27) from yeast strain RP01, which is
PRP5;cus2 (Fig. 1 and ref. 27), or RP51–62, which is prp5-
1;cus2 (Figs. 1–3 and ref. 27). Splicing reactions and native gel
analysis were done by using in vitro transcribed RP51A pre-
mRNA (Figs. 1 and 2) or actin pre-mRNA (Fig. 3 and ref. 27).
Unless otherwise noted, reactions and preincubations were at
25°C. ATP depletions were during preincubation with 0.2 mM
glucose added to splicing extract plus buffer.
Recombinant Proteins. rPrp5 and rPrp5-GNT protein were iso-
lated from Escherichia coli by successive binding to anti-FLAG
and nickel-nitriloacetic acid columns to 6HIS and FLAG tags at
the N terminus of both proteins. These were added to splicing
reactions to a final reaction concentration of 4 nM. Recom-
binant Cus2p (rCus2p) purification was described in ref. 26, and
this protein was supplemented to a final concentration of 200
nM. For treatment A in Fig. 2, rCus2p or buffer D were added
to splicing extract plus splicing buffer plus 0.2 mM glucose and
Fig. 1. Prp5p has ATP-dependent and ATP-independent roles in prespliceo-
some assembly. Shown is native gel analysis of spliceosome assembly in
ATP-depleted splicing extracts. Data are derived from a strain carrying prp5-1
and cus2 (5-1 CUS2) preincubated at 25°C (lanes 1–4) or preincubated at
37°C (lanes 5–12) for 10 min (lanes 5–8) or 20 min (lanes 9–12). Data in lanes
13–16 are from a control extract carrying PRP5 and cus2 (5CUS2) pre-
incubated at 37°C. Spliceosome assembly is analyzed in the presence (; lanes
1, 2, 5, 6, 9, 10, 13, and 14) or absence (; lanes 3, 4, 7, 8, 11, and 12) of
exogenous ATP and the presence (; lanes 2, 4, 6, 8, 10, 12, 14, and 16) or
absence (; lanes 1, 3, 5, 7, 9, 11, 13, and 15) of rPrp5 protein. CC1 and CC2,
commitment complexes; PSP, prespliceosomesspliceosomes.
Fig. 2. Cus2p acts before Prp5p to control the ATP dependence of prespli-
ceosome assembly in vitro. Shown is native gel analysis of spliceosome for-
mation in the presence (; lanes 1–3 and 7–9) or absence (; lanes 4–6 and
10–12) of ATP in experiments in which rCus2p is added before (A; lanes 2, 5,
8, and 11) or together with (B; lanes 3, 6, 9, and 12) rPrp5p to prp5-1, cus2
splicing extracts preincubated at 25°C (lanes 1–6) or 37°C (lanes 7–12). In lanes
1, 4, 7, and 10, no recombinant protein was added. Bracketed species are as in
Fig. 1.
Fig. 3. rPrp5-GNT protein can rescue splicing in the absence of Cus2p in vitro.
Shown is denaturing gel analysis of splicing in prp5-1;cus2 splicing extracts
preincubated at 25°C (lanes 2–6) or 37°C (lanes 7–11) for 30 min with buffer
D (lanes 2, 3, 5, 7, 8, and 10) or rCus2p (lanes 4, 6, 9, and 11). Subsequent
addition of buffer D (lanes 2 and 7), rPrp5p (lanes 3, 4, 8, and 9), or rPrp5-GNTp
(lanes 5, 6, 10, and 11) was 2 min before pre-mRNA, and the reactions were
incubated at 25°C for 15 min. Lanes 1, 2, and 7 have no recombinant protein
added, with lane 1 also lacking splicing extract. Labeled products (from top to
bottom) are lariat 3 exon intermediate, lariat product, pre-mRNA, splice exon
product, and free 5 exon intermediate.
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preincubated for 10 min at 25°C or 37°C. For treatment B,
preincubation proceeded without rCus2p, which was added with
rPrp5p and pre-mRNA plus ATP. In Fig. 3, rCus2p or buffer D
was added to splicing extract plus splicing buffer and preincu-
bated for 30 min at the indicated temperature. Note that ATP
was not depleted from reactions in Fig. 3. rPrp5p or rPrp5-GNT
was added 2 min before pre-mRNA plus ATP. After pre-mRNA
addition, splicing reactions in Figs. 2 and 3 were incubated for 15
min at 25°C.
Construction of Strain DS4D. Strain DS4D; MATa, prp5::KanR,
cus2::KanR, SNR20::HIS3, trp1, ura3, leu2, lys2, pIP45 (PRP5 plus
SNR20 on URA) was made by crossing YIP90; MATa,
prp5::KanR, SNR20::HIS3, trp1, ura3, leu2, pIP45 (PRP5 plus
SNR20 on URA) with BY4742cus2. Tetrad dissection and
spore analysis were done by using standard genetic techniques.
SNR20 is the standard name for the yeast U2 gene.
Analysis of Prp5 and U2 snRNA Mutants. Mutant U2 alleles are
cloned on centromeric LEU2 plasmids. U2-WT and U2-G100A
are as described in ref. 30. U2-A52G;U63C, U2-U54C;A61G,
U50G;A65C, U2-CC, and U2-A52G;U63C plus U50G;A65C
were made by site-directed mutagenesis by using the pRS315-U2
template. CUS2 is on pRS317 (centromeric plasmid with LYS2),
and PRP5, PRP5-GAT, PRP5-GHT, and PRP5-GNT are on
pRS314 (centromeric plasmid with TRP1). Yeast strain DS4D
was transformed with pRS317 or pRS317CUS2 selecting for
LYS, then cotransformed with U2 and Prp5 mutant plasmids
selecting on dextrose plates lacking lysine, tryptophan, and
leucine. The phenotype of combinations of mutant Prp5, Cus2p,
and U2 were determined by shuffling out the pIP45 plasmid
encoding wild-type U2 and Prp5p on plates containing 5-fluo-
roorotic acid and lacking lysine, tryptophan, and leucine at 30°C
for 3–5 days.
Results
Prp5p Is Required for Prespliceosome Formation in the Absence of
ATP. Prespliceosome formation can occur in vitro without ATP if
Cus2p is absent or U2 RNA is altered, but it cannot occur in
heat-treated temperature-sensitive prp5-1 extracts lacking Cus2p
(27). Thus, although the ATP requirement is relieved by the
absence of Cus2p, the requirement for Prp5p in splicing appears
not to be bypassed by the absence of Cus2p. This suggested, but
did not prove, that a function of Prp5p is required in the absence
of ATP. To address this, we asked whether addition of rPrp5p (7)
can reconstitute prespliceosome formation in heat-treated
prp5-1, cus2 splicing extracts in the absence of ATP (Fig. 1).
Treatment of these extracts at 37°C inactivates assembly of
prespliceosomes on rp51A pre-mRNA whether ATP is present
or not (Fig. 1, lanes 5, 7, 9, and 11) (27). Addition of rPrp5p
restores formation of prespliceosomes (Fig. 1, lanes 6 and 10),
even in the absence of ATP (lanes 8 and 12). Control reactions
in which prp5-1;cus2 extracts are preincubated at 25°C (lanes
1–4) or in which PRP5;cus2 extracts are preincubated at 37°C
(lanes 13–16) lead to efficient prespliceosome formation under
all treatment conditions. We conclude that the function of Prp5p
in prespliceosome formation can be uncoupled from ATP
hydrolysis in vitro if Cus2p is absent. Thus, Prp5p has two
activities: an ATP-independent activity essential for prespliceo-
some formation, and an ATP-dependent activity that is essential
in vitro only when Cus2p is present. This indicates that the
prespliceosome formation observed in the absence of ATP and
Cus2p (27) is due to the ATP-independent activity of Prp5p.
Ordered Addition of rCus2p Blocks the Function of rPrp5p in the
Absence of ATP. ATP dependence of prespliceosome formation
can be restored in cus2 extracts by the addition of rCus2p, and
this activity requires residues in the first Cus2p RNA recognition
motif (27). To analyze how Cus2p influences Prp5p function, we
performed order-of-addition experiments (Fig. 2) in which we
added rCus2p before (treatment A) or together with (treatment
B) rPrp5p to heat-treated or mock-treated prp5-1;cus2 splicing
extracts, and we assessed prespliceosome formation with (Fig. 2,
lanes 1–3 and 7–9) or without (lanes 4–6 and 10–12) ATP. If
ATP is present, both treatments reconstitute prespliceosome
formation (Fig. 2, compare lane 7 to lanes 8 and 9). In the
absence of ATP, treatment A fails to rescue prespliceosome
formation (Fig. 2, compare lanes 10 and 11), although treatment
B (both proteins together) reconstitutes prespliceosome forma-
tion (lane 12). In control reactions to which rCus2-Y48Dp is
added (a mutant Cus2p that cannot bind RNA) (26), the ATP
dependence of prespliceosome is not enforced (data not shown
and ref. 27). Thus, Cus2p blocks the ATP-independent activity
of Prp5p necessary for prespliceosome formation. To impose this
block, Cus2p must be present in the extract before Prp5p and
requires its RNA binding activity. This finding suggests that,
rather than directly binding to Prp5p, Cus2p binds or modifies a
substrate of Prp5p, either the U2 snRNP or the commitment
complex. Furthermore, this finding shows that an ATP-
dependent function of Prp5p is required to overcome the Cus2p
block of the Prp5p ATP-independent function and suggests that
antagonism of Prp5p by Cus2p represents the ATP requirement
for prespliceosome assembly observed in yeast splicing extracts.
A Prp5p ATP-Binding Domain Mutant Rescues Splicing in Vitro, but
Only When Cus2p Is Absent. If the presence of Cus2p enforces the
requirement for an ATP-dependent function of Prp5p, then
mutant Prp5 protein unable to bind ATP might rescue prespli-
ceosome formation and splicing, as long as Cus2p is absent. The
invariant lysine of the conserved GKT, the Walker A motif (31)
of the DEXDH box protein family, contacts the  and 
phosphates of bound nucleotides in the crystal structures of
several NTPases (32–34). Lysine (K) to alanine (A), asparagine
(N), or glutamine (Q) substitution in this motif of various
DEXDH family members results in loss of function and sig-
nificant reduction in ATP-binding and ATP-hydrolysis activities
(32–38). Thus, we made rPrp5p containing the GKT lysine to
asparagine substitution, rPrp5-GNTp, and asked whether this
protein could rescue splicing of actin pre-mRNA in heat-treated
prp5-1;cus2 splicing extracts (Fig. 3).
Preincubation of prp5-1;cus2 extracts for 30 min at 37°C
results in a drastic reduction in splicing as measured by the
increase in unspliced pre-mRNA and the reduction in splicing
intermediates and products (Fig. 3, lane 7). Addition of rPrp5p
(Fig. 3, lane 8) or rPrp5-GNTp (lane 10) during the heat
treatment can rescue this splicing, but the addition of rCus2p
reduces rescue by rPrp5p (lane 9) and completely inhibits rescue
by rPrp5-GNTp (lane 11). From this we conclude that rPrp5-
GNT can rescue splicing in heat-inactivated prp5-1;cus2 splic-
ing extracts, but only when Cus2p is absent. Preincubation of
prp5-1;cus2 extract at 25°C with no protein (Fig. 3, lane 2),
rPrp5p (lane 3), rCus2p plus rPrp5p (lane 4), rPrp5-GNT (lane
5), or rCus2p plus rPrp5-GNT (lane 6) demonstrates that the
addition of these recombinant proteins does not generally affect
splicing activity. Although we have not determined that rPrp5p-
GNT is inhibited for ATP binding and hydrolysis, this experi-
ment supports the observation that wild-type rPrp5p rescues
prespliceosome formation in the absence of ATP (Fig. 2). The
above experiment also suggests that the requirement for ATP
hydrolysis by Prp5p is limited to prespliceosome assembly and is
not necessary for other ATP-requiring steps in splicing.
The prp5-GNT Gene Can Rescue a PRP5 Deletion in Vivo, but Only When
CUS2 Is Deleted. If the in vitro results above represent an accurate
picture of Prp5p function in vivo, then Prp5p mutants lacking
ATP-binding residues might support growth if Cus2p is absent








from the cell. To test this, we constructed a yeast strain deleted
for CUS2 and carrying the prp5-GNT allele. Cells carrying this
PRP5 mutation are able to grow only if they also carry the CUS2
deletion (Fig. 4), demonstrating that the conserved ATP binding
residues are not critical when Cus2p is absent in vivo. These
observations show that, in vivo as well as in vitro, efficient ATP
binding by Prp5p is not required for splicing if Cus2p is absent.
U2 snRNA Mutations Suppress the Lethal Effects of More Severe PRP5
ATP-Binding Domain Mutations. If Prp5p unwinds RNA, U2
snRNA is a likely substrate. Of several RNAs tested, U2 RNA
fragments proved best at activating the ATP-hydrolyzing activity
of rPrp5p (7). Oligonucleotide-based probing methods suggest
that Prp5p modifies U2 snRNP structure in an ATP-dependent
fashion (7, 11). We reasoned that, if U2 RNA is the target of
Prp5p ATP-dependent activity, mutations in U2 RNA that are
less dependent on these functions might be able to suppress
defects caused by ATP-binding-deficient Prp5p proteins in vivo.
In addition to the prp5-GNT allele, we made two other ATP-
binding domain alterations, prp5-GAT and prp5-GHT. These
alleles are more severely affected, because neither can comple-
ment a PRP5 deletion in a wild-type U2 background, even when
CUS2 is deleted (Table 1). We screened a pool composed of
available U2 snRNA mutations (30, 35), including a complex
library of U2 mutations (29) and several mutants that hypersta-
bilize stem IIa directly or disrupt structures that compete with
stem IIa (35). None of the mutant U2 alleles tested display any
growth defects in wild-type (CUS2, PRP5), or cus2, PRP5
backgrounds (refs. 29, 33, and 35 and data not shown).
Strikingly, a subset of U2 snRNA mutants suppresses the
lethal effects of prp5-GAT or prp5-GHT (Table 1 and Fig. 5A),
suggesting that they further relieve the requirement for Prp5p
function. Among these are U2 alleles in which stem IIa stability
seems increased by one of several mechanisms: substituting A-U
base pairs in stem IIa with G-C pairs (Fig. 5B), reducing the
potential pairing between the loop of stem loop IIa and the
conserved complementary region (G100A), or completely de-
leting the conserved complementary region (CC). In the cus2
background, the prp5-GAT allele is rescued by all six mutant U2
snRNA alleles, whereas prp5-GHT is rescued by a subset of these
(Table 1). None of the mutant U2 snRNA alleles is able to
suppress prp5-GAT or prp5-GHT in the presence of CUS2;
however, all of the U2 mutants suppress the lethal effects of
prp5-GNT in the presence of CUS2 (Table 1). These data
indicate that increasing the stability of U2-stem IIa in the
absence of Cus2p allows cell viability even with severe Prp5-GKT
mutant alleles.
Discussion
By reconstituting splicing extracts lacking Prp5p and Cus2p
activity with recombinant proteins, we demonstrate that the
DEXDH box family member Prp5p has a role in U2 snRNP
recruitment that is independent of ATP hydrolysis (Figs. 1–3).
We find a strict requirement for Cus2p to be present before
Prp5p to enforce the ATP dependence of U2 snRNP addition
observed in wild-type extracts (Fig. 2). The conclusion that
Cus2p enforces an ATP-dependent activity of Prp5p is sup-
ported by the following observations. First, mutations in the
conserved GKT ATP-binding motif of Prp5p rescue splicing in
vitro (Fig. 3), only if Cus2p is absent. Second, the same mutant
PRP5 allele can support growth in vivo (Figs. 4 and 5 and Table
1), but, again, only when CUS2 is deleted. Some GKT ATP-
binding motif mutants are more severe, and, in addition to cus2,
require hyperstabilized U2-stem IIa for rescue in vivo (Fig. 5 and
Table 1), suggesting that U2-stem IIa formation may also be
aided by ATP-dependent Prp5p activity. We conclude that the
ATP-dependent functions for Prp5p involve removing Cus2p
from the U2 snRNP and helping stabilize U2 stem IIa before
prespliceosome formation. Because Prp5p is essential even when
the ATP-dependent demands are removed, we also propose an
ATP-independent activity for Prp5p in stabilizing the binding of
U2 to the pre-mRNA branchpoint.
A Model for Cus2p and Prp5p Control of U2 snRNA and snRNP Function.
Previous work has demonstrated complex functional links
among Cus2p, Prp5p, and U2 snRNA. First, a set of genetic
interactions indicates that each gene product contributes to
splicing function and that each supports the function of the other
two (6, 7, 11, 25–28). Second, biochemical evidence supports the
idea that these gene products function together. Both Cus2p and
Prp5p coimmunoprecipitate U2 snRNA in yeast (11, 25), and
human Prp5 is a component of the 17S U2 snRNP (25).
Furthermore, U2 RNA fragments stimulate rPrp5p ATPase
activity in vitro (7). Finally, there is a negative effect of Cus2p on
the ATP-dependent addition of the U2 snRNP, because, in the
absence of Cus2p, this step no longer requires ATP in vitro (27).
Fig. 4. Prp5-GNT can rescue growth in the absence of Cus2p in vivo. Strain
DS4D (prp5;cus2;u2) carrying pRS315U2 and either pRS317 (right half) or
pRS317CUS2 (left half) plus one of pRS314, pRS314Prp5, or pRS314Prp5-
GNT plasmids plated on 5-fluoroorotic acid-Lys-Trp-Leu at 30°C for 5 days.
Table 1. Growth of PRP5 and U2 mutants with and
without CUS2
U2 CUS2 PRP5
wt GAT GNT GHT
wt wt    
    
G100A wt    
    
CC wt    
    
A52G;U63C wt    
    
U50G;A65C wt    
    
U50G;A65C  wt    
A52G;U63C     
U54C;A61G wt    
    
Strain DS4D deleted of the PRP5, CUS2, and U2 genes and carrying PRP5 and
U2 on a URA3 plasmid were transformed with the indicated U2, PRP5, and
CUS2 plasmids, and then wild-type PRP5 and U2 were removed by plasmid
shuffling on plates containing 5-fluoroorotic acid for 5 days at 30°C. The
number of plus signs indicates the level of growth.
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In this article we show that this negative effect of Cus2p is
specific for the ATP-dependent activity of Prp5p itself, because
(i) Prp5p but not ATP is required for prespliceosome assembly
in vitro if Cus2p is absent (Figs. 1 and 2), and (ii) Prp5
ATP-binding site mutants are functional only in the absence of
Cus2p in vitro (Fig. 3) and in vivo (Figs. 4 and 5 and Table 1).
Taken together, these data suggest a model for how Cus2p and
Prp5p work with the U2 snRNP during prespliceosome assembly
(Fig. 6). The positive role of Cus2p is to help refold U2 snRNA
to make the U2 snRNP active for prespliceosome assembly (26).
In this view, Cus2p helps create a form of the U2 snRNP (the
‘‘activated U2 snRNP’’) that is an efficient substrate for Prp5p.
This is not an essential function, so activation of the U2 snRNP
can occur without Cus2p. However, mutant U2 RNAs with
folding defects are dependent on Cus2p (26), suggesting that
activation of the U2 snRNP requires correct U2 snRNA folding.
When Prp5p function is compromised, as in the temperature-
sensitive alleles, the positive function of Cus2p becomes essential
(27). It is possible that Cus2p contributes to Prp5p function
indirectly by increasing the levels of activated U2 snRNP in vivo.
To incorporate the negative effect of Cus2p on the ATP-
dependent activity of Prp5p (ref. 27 and Fig. 2), we suggest that
Cus2p occupies a site on the U2 snRNP that Prp5p must access
to promote stable association of the U2 snRNP with pre-mRNA.
In this view, Cus2p is displaced from the U2 snRNP by an
ATP-dependent function of Prp5p before Prp5p can stabilize U2
association with pre-mRNA. In the absence of Cus2p, Prp5p has
full access to the U2 snRNP and does not need ATP to perform
the latter function (Fig. 6).
How does folding of U2 snRNA fit into this process? Hyper-
stabilizing stem IIa rescues GKT mutants (Fig. 5 and Table 1).
Because aiding stem IIa formation would seem to reduce the
demand for ATP binding, this finding suggests that stem IIa
could be the end product of a Prp5p unwinding activity that acts
on competing structures (for an example, see ref. 35). A Prp5p
role in modifying U2 snRNA structure has been suggested (6, 7,
11, 27, 28, 44). Wiest et al. (44) and O’Day et al. (7) proposed
alternate U2 snRNA states by assaying U2 branchpoint inter-
action region accessibility to oligonucleotide binding and
RNaseH cleavage in inactivated prp5-1 yeast splicing extracts.
When no Prp5p is present U2 RNA is less accessible and a closed
state is proposed, but when active Prp5p and ATP are present U2
RNA becomes accessible and an open state is proposed. If so, the
ATP-dependent functions of Prp5p may be involved in two
distinct activities: (i) to remove Cus2p and (ii) to unwind helices
that oppose stem IIa formation. Alternatively, a more stable
form of stem IIa could contribute indirectly to Prp5p general
function by increasing the levels of activated U2 snRNP. This
possibility is consistent with the interpretation that Cus2p helps
form the activated the U2 snRNP in part by stabilizing stem
IIa (26).
Whether or not Prp5p unwinds U2 snRNA, the model de-
scribes a plausible pathway for wild-type prespliceosome assem-
bly inferred from the phenotype of mutants and from ordered
reactions in extracts depleted of ATP and supplemented with
recombinant proteins. The two main features of the model are
that Cus2p contributes early to U2 snRNP activation but then
must be removed, and that Prp5p has an ATP-dependent
function that removes Cus2p and an ATP-independent function
that stabilizes binding of the U2 snRNP to the pre-mRNA
branchpoint.
Multiple Functions for Prp5p. Our experiments have resolved
ATP-dependent and ATP-independent roles for Prp5p in U2
snRNP recruitment to the pre-mRNA branchpoint. An ATP-
independent function for Prp5p was first suspected when cus2
Fig. 5. U2 snRNA mutations that hyperstabilize U2-stem IIa suppress prp5-
GAT. (A) Growth of strains. Strain DS4D plus pRS317 (upper half) or
pRS317CUS2 (lower half) was transformed with pRS314Prp5 or pRS314Prp5-
GAT plus one of wild-type U2, U2-A52G;U63C, U50G;A65C, or U2-CC and
plated on 5-fluoroorotic acid-Lys-Leu-Trp at 30°C for 5 days. (B) Secondary
structure of nucleotides 29–120 of yeast U2 snRNA. Nucleotide substitutions
for U2 snRNA mutant alleles A52G;U63C, U50G;A65C, G100A, and CC are
shown.
Fig. 6. A model for the roles of Cus2p and the ATP-dependent activity of
Prp5p in U2 snRNP recruitment and prespliceosome formation. Cus2p binds U2
snRNA and helps form stem IIa during formation of the activated U2 snRNP
and engagement with pre-mRNA. The ATP-dependent functions of Prp5p
include removing Cus2p, and stabilizing U2-stem IIa. This may include unwind-
ing competing RNA structures to form stem IIa. The ATP-independent function
is required for stable U2 snRNP-pre-mRNA binding.








extracts able to support prespliceosome assembly in the absence
of ATP failed to do so when prp5-1 was heat-inactivated (27).
Using recombinant protein we now show that the missing activity
required for prespliceosome assembly in the absence of ATP is
Prp5 (Figs. 1 and 2). Supporting this is the observation that
ATP-binding site mutants (GKT mutants) complement splicing
in vitro (Fig. 3) and growth in vivo (Fig. 4 and Table 1) when
Cus2p is absent, arguing that core Prp5 function does not require
ATP or efficient binding of ATP to Prp5p. Although we have not
assayed the ATP binding of the Prp5-GKT mutants, we are
confident that they are significantly reduced, because equivalent
lysine substitutions in other DEXDH box proteins show neg-
ligible ATP-dependent protein activity (36–40). However, we
cannot discount the possibility that the three PRP5 alleles may
have subtle differences in residual ATP binding, and this could
explain variations in viability we observe in the presence of
different U2 snRNA alleles as well as their different responses
to the presence of Cus2p (Table 1). Clearly however, if any PRP5
ATP-binding activity remains, it is not enough to support growth
in wild-type cells.
The ATP-dependent functions of Prp5p are uncovered only
when they are bypassed and an ATP-requirement is relieved.
One ATP-dependent function for Prp5p is to overcome the
presence of Cus2p (ref. 27 and Figs. 1 and 2). Similarly, when
stem IIa is hyperstabilized, the requirement for ATP binding site
residues becomes less stringent in vivo (Fig. 5 and Table 1),
suggesting that another ATP-dependent function is to stabilize
stem IIa. We do not know to what extent these two ATP-
dependent functions are related, but it seems possible to both
remove Cus2p and stabilize a defined structure of U2 snRNA (as
well as making other changes) by a single structural rearrange-
ment that remodels the U2 snRNP. The ATP-independent step
could involve a conformational change in Prp5p that can occur
without ATP hydrolysis. Alternatively, because Prp5p extends
290 aa N-terminally and 230 aa C-terminally from the conserved
helicase core, these regions may contain elements directly
required for the ATP-independent functions.
Prp5p is the second DEXDH box protein family member for
which ATP-dependent and ATP-independent roles have been
demonstrated. Elegant work by Schwer and colleagues (18, 41)
has resolved multiple roles for Prp22p before and after the
second catalytic step of splicing. Prp22 mutants incapable of
ATP hydrolysis can perform a Prp22p function required for the
second step of splicing but cannot supply function for mRNA
release from the spliceosome (18, 41). Prp5p appears different
in that its ATP-dependent function is required to act before its
ATP-independent function. Yeast cells with prp5 alleles altered
in critical ATP-binding residues are inviable in an otherwise
wild-type background. Requirement for these Prp5p residues is
bypassed by CUS2 deletion (Figs. 4 and 5 and Table 1). This is
the third such example of bypass of an essential DEXDH box
family protein in the splicing pathway. Deletion of MUD2
removes the requirement for the DEXDH protein Sub2p (8),
whereas specific alterations in U1-C protein eliminate the need
for the DEXDH box protein Prp28p (42). These findings
demonstrate that removal of a specific protein or protein activity
renders the ATP hydrolysis function of the corresponding
DEXDH protein dispensable in vivo and suggests that their
primary ATP-driven function is to overcome the antagonizing
effects of specific target proteins. DEXDH box protein family
members hydrolyze ATP to alter RNA structures (for a review,
see ref. 24); however, these proteins could also disrupt RNA–
protein complexes (4, 23, 43).
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